Letter: Prognosis in myocardial infarction

State of the art approach to managing angina and ischemia: tailoring treatment to the evidence.

European journal of internal medicine·2021

Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.

Herz·2013

Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies.

Minerva cardioangiologica·2003

Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials.

Current opinion in cardiology·2001

The Connecticut Cardiovascular Consortium: a unique, state-wide research collaboration to advance clinical outcomes in patients with heart disease.

Connecticut medicine·2001

Defining the optimal pharmacotherapy of non-ST-segment elevation (NSTE) acute coronary syndromes (ACS): a rapidly moving target.

Current opinion in cardiology·2001

Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.

Annals of internal medicine·2026

Inflammatory Bowel Disease.

Annals of internal medicine·2026

Surgery Versus Watchful Waiting for First Metatarsophalangeal Joint Osteoarthritis : A Randomized Controlled Trial.

Annals of internal medicine·2026

How Would You Manage Perioperative Cardiovascular Risk for Noncardiac Surgery in This Patient With Complex Comorbidity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Annals of internal medicine·2026

In large-core ischemic stroke with onset in the past 24 h, EVT vs. medical therapy improves functional outcomes and reduces mortality at 90 d.

Annals of internal medicine·2026

In veterans with chronic pain, a whole health team intervention reduced pain interference more than CBT or usual care at 12 mo.

Annals of internal medicine·2026

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Revista colombiana de obstetricia y ginecologia·2026

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

The Medical journal of Malaysia·2026

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Journal of the American College of Cardiology·2026

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Journal of the American College of Cardiology·2026

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Journal of viral hepatitis·2026

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

European heart journal·2026

Related Experiment Videos

Letter: Prognosis in myocardial infarction

Related Concept Videos

State of the art approach to managing angina and ischemia: tailoring treatment to the evidence.

Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.

Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies.

Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials.

The Connecticut Cardiovascular Consortium: a unique, state-wide research collaboration to advance clinical outcomes in patients with heart disease.

Defining the optimal pharmacotherapy of non-ST-segment elevation (NSTE) acute coronary syndromes (ACS): a rapidly moving target.

Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.

Inflammatory Bowel Disease.

Surgery Versus Watchful Waiting for First Metatarsophalangeal Joint Osteoarthritis : A Randomized Controlled Trial.

How Would You Manage Perioperative Cardiovascular Risk for Noncardiac Surgery in This Patient With Complex Comorbidity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

In large-core ischemic stroke with onset in the past 24 h, EVT vs. medical therapy improves functional outcomes and reduces mortality at 90 d.

In veterans with chronic pain, a whole health team intervention reduced pain interference more than CBT or usual care at 12 mo.

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

Related Experiment Videos

Letter: Prognosis in myocardial infarction

Related Concept Videos

Related Articles